Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells

Lipid nanoemulsions (NEs) are promising green nanocarriers for diagnostic and therapeutic applications, but their functionalization with biomolecules, such as antibodies, remains a challenge due to liquid nature of their core. Here, we developed an original plug-and-play strategy to graft an antibody (trastuzumab) at the surface of NEs, using components generally recognized as safe (GRAS). We synthesized a reactive 4-nitrophenyl carbonate of cholesterol (NPC-Chol) and a Biotin-PEG<sub>3000</sub>-Lysine linker, which can react within one-pot formulation to form an amphiphilic carbamate Biotin-PEG<sub>3000</sub>-Cholesterol. The cholesterol ensures anchorage of the linker, which effectively exposes biotin moiety at the surface of NEs for further antibody grafting using a biotin-neutravidin coupling. The reaction between the Biotin-PEG<sub>3000</sub>-Lysine linker and NPC-Chol was confirmed by <sup>1</sup>H-NMR and absorption spectroscopy. The obtained biotinylated 50-nm NEs loaded with a near-infrared dye were successfully targeted to neutravidin-coated glass surfaces and imaged at the single-droplet level. The biotinylated NEs bearing the trastuzumab antibody targeted specifically HER2-amplified breast cancer models HCC-1954 and SKBR3, in contrast to control MDA-MB-231 (HER2-low) cells. Altogether, our study proposes an efficient methodology for grafting antibodies to the surface of NEs, which offers new opportunities of application of these green nanocarriers in biomedicine.

Authors

Institutions

Publication Details

Journal
Nanoscale Advances
Published
2025-01-01
DOI
https://doi.org/10.1039/d5na00606f
Citations
2
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
1.19

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells

Nicolas Anton, Jacky G. Goetz, Vincent Mittelheisser, Bohdan Andreiuk et al.
2 citations
Nanoscale Advances
Nanoparticle-Based Drug Delivery
1.19
article

Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells

Nicolas Anton, Jacky G. Goetz, Vincent Mittelheisser, Bohdan Andreiuk, Olivier Lefèbvre, Andrey S. Klymchenko, Valeria Jose Boide-Trujillo, Fei Liu
article en
2 citations

Abstract

Lipid nanoemulsions (NEs) are promising green nanocarriers for diagnostic and therapeutic applications, but their functionalization with biomolecules, such as antibodies, remains a challenge due to liquid nature of their core. Here, we developed an original plug-and-play strategy to graft an antibody (trastuzumab) at the surface of NEs, using components generally recognized as safe (GRAS). We synthesized a reactive 4-nitrophenyl carbonate of cholesterol (NPC-Chol) and a Biotin-PEG<sub>3000</sub>-Lysine linker, which can react within one-pot formulation to form an amphiphilic carbamate Biotin-PEG<sub>3000</sub>-Cholesterol. The cholesterol ensures anchorage of the linker, which effectively exposes biotin moiety at the surface of NEs for further antibody grafting using a biotin-neutravidin coupling. The reaction between the Biotin-PEG<sub>3000</sub>-Lysine linker and NPC-Chol was confirmed by <sup>1</sup>H-NMR and absorption spectroscopy. The obtained biotinylated 50-nm NEs loaded with a near-infrared dye were successfully targeted to neutravidin-coated glass surfaces and imaged at the single-droplet level. The biotinylated NEs bearing the trastuzumab antibody targeted specifically HER2-amplified breast cancer models HCC-1954 and SKBR3, in contrast to control MDA-MB-231 (HER2-low) cells. Altogether, our study proposes an efficient methodology for grafting antibodies to the surface of NEs, which offers new opportunities of application of these green nanocarriers in biomedicine.

Nanoscale AdvancesVol. 7(22)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Regenerative NanoMedicine (FR), Laboratoire de Biophotonique et Pharmacologie (FR), La Ligue Contre le Cancer (FR), Université de Strasbourg (FR)
Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Université de Strasbourg, Ligue Contre le Cancer, China Scholarship Council, Institut National Du Cancer, National Cancer Institute
Openalex Percentile: Top 19%
Nanoparticle-Based Drug Delivery
1.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.